Presentations
Presentations
2021
-“A sphingolipid-guided gene expression signature stratifies acute myeloid leukemia prognosis.” Mid-Atlantic Postdoc Symposium. (Virtual)
2020
- “An Integrative Gene Expression and Mathematical Flux-Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.” 2020 NCI CSBC Annual Meeting. (Virtual)
- “Altered Nucleo-Cytoplasmic Transport and Epigenetic States in ERBB-Activated Breast Epithelia.” 2020 NCI CSBC Annual Meeting. (Virtual)
- “An Integrative Gene Expression and Mathematical Flux-Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.” 2020 NCI CSBC/PS-ON/BD-STEP Junior Investigators Meeting. (Virtual)
- “Modeling Cell Interaction to Explore Population Dynamics in Cancer Cells.” Cell Modeling Hackathon 2020, Half Moon Bay, CA.
2019
- “Disrupting Redox Balance Enhances the Effects of Targeted Therapies in Melanomas.” Vanderbilt University Postdoctoral Association 13th Annual Symposium 2019, Nashville, TN. (oral presentation)
- “Enhancing the therapeutic benefits of BRAF-inhibitors by modulating redox balance.” Vanderbilt University Department of Biochemistry Annual Retreat 2019, Nashville, TN. (oral presentation)
- “Overcoming Intrinsic Resistance to BRAF-inhibitors by Modulating Redox Balance in BRAF-mutated Melanoma Cells.” 2019 American Association for Cancer Research (AACR) Annual Meeting. Atlanta, GA.
2018
- “Enhancing the therapeutic benefits of BRAF-inhibitors by modulating redox balance in BRAF-mutated Melanomas.” Vanderbilt University Department of Biochemistry Student Association (BSA) Colloquium 2018, Nashville, TN.
- “Drug response epigenetic landscape of BRAF-mutated melanoma cells.” Systems Approaches to Cancer Biology (SACB) 2018, Woods Hole, MA. (oral presentation)
- “Drug Response Heterogeneity and Emergence of “Idling” Phenotype in BRAF-mutated Melanomas.” CSBC/PS-ON Junior Investigator Meeting, Bethesda, MD. (oral presentation)
- “Drug Response Landscape of BRAF-Mutated Melanoma Cells: Non-Quiescent”Idling Population State” As an Alternative Drug Persistence.” Society for Biological Engineering, Cell Therapies and Bioengineering Conference, San Francisco, CA. (oral presentation)
- “A Non-Quiescent, “Idling” Population State in Drug-Treated BRAF-Mutated Melanoma.” Quantitative Systems Biology Center (QSBC) Biweekly Seminar, Vanderbilt University, Nashville, TN.
- “To Divide or Die: Cellular Response Under Continued Drug Perturbations.” Department of Cancer Biology Science Hour, Vanderbilt University, Nashville, TN.
- “Drug Response Heterogeneity and Emergence of “Idling” Phenotype in BRAF-mutated Melanomas.” 2018 CSBC/PS- ON Annual Investigator Meeting, Bethesda, MD.
- “Drug Response Landscape in BRAF-mutated Melanoma Cells.” 11th Annual International Conference on Systems Biology of Human Diseases (SBHD), UCLA, Los Angeles, CA.
- “Drug Response Landscape of BRAF-mutated Melanoma Cells.” Vanderbilt-Ingram Cancer Center Annual Scientific Retreat “Microbiome and Cancer”, Nashville, TN.
2017
- “Drug Response Dynamics in BRAF-mutated Melanoma Cells.” 2017 Chemical and Physical Biology Annual Retreat, Vanderbilt University, Nashville, TN.
2016
- “A Non-Quiescent Idling State in Drug-Treated BRAF-mutated Melanoma Cells.” Department of Cancer Biology Science Hour, Vanderbilt University, Nashville, TN.
- “A Non-Quiescent Idling State in Drug-Treated BRAF-mutated Melanoma Cells.” 10th Annual q-bio Conference, Nashville, TN. (Poster Spotlight Talk).
- “Heterogeneity and complex drug response dynamics in BRAF-mutated melanoma cells.” Department of Cancer Biology Science Hour, Vanderbilt University, Nashville, TN.
- “A Non-Quiescent “Idling” State in Drug-Treated BRAF-mutated Melanoma Cells.” Society for Melanoma Research (SMR) 2016 International Congress, Boston, MA.
2015
- “Complex drug-response dynamics in BRAF-mutated melanoma cell populations.” Society for Melanoma Research (SMR) 2015 International Congress, San Francisco, CA.
- “Understanding complex drug response behavior of BRAF-mutated melanoma cells treated with targeted therapies.” 2015; Interagency Modeling and Analysis Group (IMAG), Multiscale Modeling (MSM) Consortium, Bethesda, MD.
- “Understanding Drug Response Heterogeneity in BRAF-mutated Melanomas in Response to Targeted Therapies.” Stochastic Physics in Biology, Gordon Research Conference, Ventura Beach, CA.